마이크로바이옴 친화적 유효 성분 시장 예측(-2032년) : 성분 유형, 형태, 기술, 유통 채널, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Microbiome-Friendly Actives Market is accounted for $311.6 million in 2025 and is expected to reach $1,597.3 million by 2032 growing at a CAGR of 26.3% during the forecast period. Microbiome-Friendly Actives are bioactive ingredients specifically formulated to support, protect, and balance the human skin or gut microbiome-the complex ecosystem of beneficial microorganisms that maintain health. These actives work by promoting the growth of beneficial bacteria, inhibiting harmful microbes, and preserving the natural microbial diversity essential for barrier function, immunity, and overall wellbeing. Unlike traditional chemicals that may disrupt microbial balance, microbiome-friendly actives are gentle, targeted, and often derived from prebiotics, probiotics, or postbiotics. Their application spans skincare, personal care, and nutrition, reflecting a growing consumer demand for products that nurture natural microbial health safely and effectively.

Market Dynamics:

Driver:

Rising demand for personalized skincare

The rising demand for personalized skincare is creating a strong and positive impact on the Microbiome-Friendly Actives Market. Consumers are increasingly seeking tailored solutions that align with their unique skin microbiome, driving innovation and product diversification. This trend encourages skincare brands to develop formulations that target specific needs such as sensitivity, acne, or aging, while preserving microbiome balance. As awareness about microbiome health grows, personalized approaches enhance customer trust and satisfaction, fueling market adoption and accelerating growth opportunities across the sector.

Restraint:

High R&D and formulation costs

The Microbiome-Friendly Actives Market faces a notable constraint due to high R&D and formulation costs, which hinder rapid innovation and product development. These elevated expenses increase entry barriers for smaller companies and limit the ability to scale solutions efficiently. As a result, market expansion is slowed, pricing remains elevated, and adoption by consumers and manufacturers may be restrained, ultimately impeding the sector's overall growth trajectory.

Opportunity:

Clean beauty and probiotic/prebiotic trends

The growing popularity of clean beauty and probiotic/prebiotic trends is positively driving the market, as consumers increasingly seek products that promote skin health through natural, safe, and effective formulations. Clean beauty emphasizes transparency, sustainability, and avoidance of harsh chemicals, while probiotic and prebiotic innovations support balanced skin microbiota, boosting product credibility and demand. This synergy encourages brands to integrate microbiome-friendly actives into skincare solutions, fostering innovation, consumer trust, and widespread adoption, ultimately fueling sustained market expansion.

Threat:

Regulatory ambiguity

The Microbiome-Friendly Actives Market faces a negative and hindering impact due to regulatory ambiguity, which creates uncertainty around product approvals, safety standards, and labeling requirements. Companies struggle to navigate inconsistent guidelines across regions, delaying product launches and increasing compliance costs. This uncertainty discourages investment in research and innovation, slows market expansion, and may result in limited consumer adoption, ultimately constraining the overall growth potential of the microbiome-focused health and personal care sector.

Covid-19 Impact

The Covid-19 pandemic had a mixed impact on the Microbiome-Friendly Actives Market. Initially, disruptions in supply chains, manufacturing slowdowns, and reduced consumer spending hindered growth. However, the crisis heightened awareness of immune health, gut health, and personal wellness, driving long-term demand for microbiome-based skincare and nutritional products. Consumers increasingly sought natural, safe, and science-backed solutions, positioning microbiome-friendly actives as a resilient and promising category despite short-term challenges during the pandemic.

The synbiotics segment is expected to be the largest during the forecast period

The synbiotics segment is expected to account for the largest market share during the forecast period, because of merging targeted prebiotics and probiotics into synergistic formulations that enhance gut-skin and gut-brain axes. This convergence is driving innovation in functional skincare, ingestibles, and wellness products, with rising consumer demand for holistic, bioactive solutions. Synbiotics also enable precision microbiome modulation, fostering regulatory confidence and scientific validation. As a result, they're reshaping product development pipelines and accelerating adoption across beauty, nutraceutical, and therapeutic verticals.

The serums segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the serums segment is predicted to witness the highest growth rate, due to rising consumer demand for minimalist, high-efficacy formulations, serums offer an ideal format for incorporating microbiome-balancing ingredients like postbiotics and fermented extracts. Their lightweight, targeted nature enhances ingredient bioavailability, driving innovation in active encapsulation and synergistic blends. This convergence is fostering premiumization, expanding dermocosmetic applications, and positioning microbiome-friendly actives as essential pillars of next-gen skin health.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising consumer demand for holistic wellness and scientifically backed formulations. With growing awareness of gut-skin-brain connections, brands are innovating across food, personal care, and supplements to support microbial balance. Japan and Southeast Asia lead adoption, fueled by aging populations and proactive health strategies. Regulatory shifts and regional R&D investments further accelerate growth, positioning microbiome-friendly actives as a transformative force in preventive healthcare and consumer trust.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising consumer awareness of gut-skin health connection, demand for natural and clean-label products, and a thriving personalized skincare industry. The region's advanced R&D ecosystem, presence of leading cosmetic and nutraceutical brands, and strong regulatory emphasis on safety and efficacy further accelerate market adoption. Growing investments in biotech innovations and consumer preference for probiotic and prebiotic-based actives reinforce steady growth momentum.

Key players in the market

Some of the key players profiled in the Microbiome-Friendly Actives Market include Chr. Hansen Holding A/S, DuPont, Lonza Group AG, Yakult Honsha Co., Ltd., Lesaffre Group, Nestle Health Science, Danone S.A., Evonik Industries AG, BioGaia AB, DSM-Firmenich AG, Probi AB, SynbioTech Inc., Kerry Group plc, Novozymes A/S, Herbalife Nutrition Ltd., Arla Foods Ingredients Group, Sabinsa Corporation and Morinaga Milk Industry Co., Ltd.

Key Developments:

In June 2025, Nestle has embarked on collaborations in New Zealand and the UK to explore integrated multi-trophic aquaculture, where seaweed and shellfish mutually nourish one another. This approach promises a graceful, sustainable symbiosis-boosting biodiversity, water quality, and ecosystem restoration.

In May 2025, DuPont and Epicore Biosystems have partnered to fuse DuPont's protective garment expertise with Epicore's sweat-sensing Connected Hydration wearables, aiming to deliver real-time biometrics and personalized hydration insights to enhance worker safety in heat-stress environments.

In June 2025, Ethris has partnered with Lonza to develop room-temperature-stable, spray-dried mRNA vaccine formulations for mucosal delivery via nasal administration, beginning with an influenza candidate. This method promises to simplify cold-chain logistics and enhance accessibility for respiratory disease prevention.

Ingredient Types Covered:

• Prebiotics
• Probiotics
• Postbiotics
• Synbiotics
• Botanical Extracts
• Peptides
• Vitamins & Minerals

Forms Covered:

• Capsules & Tablets
• Powders
• Liquids
• Gummies
• Creams & Lotions
• Serums
• Oils

Technologies Covered:

• Genomics-based Actives
• Metabolomics-derived Compounds
• AI-personalized Microbiome Formulations
• Encapsulation & Delivery Systems

Distribution Channels Covered:

• Hypermarkets/Supermarkets
• Specialty Stores
• Pharmacies
• Online Retail
• Dermatology Clinics

Applications Covered:

• Skin Care
• Hair Care
• Oral Care
• Feminine Hygiene
• Baby Care
• Wound Healing
• Anti-aging & Barrier Repair

End Users Covered:

• Adults
• Children
• Geriatric Population
• Pets & Livestock

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Microbiome-Friendly Actives Market, By Ingredient Type

• 5.1 Introduction
• 5.2 Prebiotics
• 5.3 Probiotics
• 5.4 Postbiotics
• 5.5 Synbiotics
• 5.6 Botanical Extracts
• 5.7 Peptides
• 5.8 Vitamins & Minerals

6 Global Microbiome-Friendly Actives Market, By Form

• 6.1 Introduction
• 6.2 Capsules & Tablets
• 6.3 Powders
• 6.4 Liquids
• 6.5 Gummies
• 6.6 Creams & Lotions
• 6.7 Serums
• 6.8 Oils

7 Global Microbiome-Friendly Actives Market, By Technology

• 7.1 Introduction
• 7.2 Genomics-based Actives
• 7.3 Metabolomics-derived Compounds
• 7.4 AI-personalized Microbiome Formulations
• 7.5 Encapsulation & Delivery Systems

8 Global Microbiome-Friendly Actives Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Hypermarkets/Supermarkets
• 8.3 Specialty Stores
• 8.4 Pharmacies
• 8.5 Online Retail
• 8.6 Dermatology Clinics

9 Global Microbiome-Friendly Actives Market, By Application

• 9.1 Introduction
• 9.2 Skin Care
• 9.3 Hair Care
• 9.4 Oral Care
• 9.5 Feminine Hygiene
• 9.6 Baby Care
• 9.7 Wound Healing
• 9.8 Anti-aging & Barrier Repair

10 Global Microbiome-Friendly Actives Market, By End User

• 10.1 Introduction
• 10.2 Adults
• 10.3 Children
• 10.4 Geriatric Population
• 10.5 Pets & Livestock

11 Global Microbiome-Friendly Actives Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Chr. Hansen Holding A/S
• 13.2 DuPont
• 13.3 Lonza Group AG
• 13.4 Yakult Honsha Co., Ltd.
• 13.5 Lesaffre Group
• 13.6 Nestle Health Science
• 13.7 Danone S.A.
• 13.8 Evonik Industries AG
• 13.9 BioGaia AB
• 13.10 DSM-Firmenich AG
• 13.11 Probi AB
• 13.12 SynbioTech Inc.
• 13.13 Kerry Group plc
• 13.14 Novozymes A/S
• 13.15 Herbalife Nutrition Ltd.
• 13.16 Arla Foods Ingredients Group
• 13.17 Sabinsa Corporation
• 13.18 Morinaga Milk Industry Co., Ltd.